Villoglandular adenocarcinoma of the cervix: Two new cases with morphological and molecular study

被引:17
作者
Giordano, Giovanna
D'Adda, Tiziana
Gnetti, Letizia
Merisio, Carla
Gabrielli, Marzio
Melpignano, Mauro
机构
[1] Univ Parma, Sect Pathol, Dept Pathol & Lab Med, I-43100 Parma, Italy
[2] Univ Parma, Sect Pathol, Dept Obstet & Gynecol Sci & Neonatol, I-43100 Parma, Italy
关键词
villoglandular adenocarcinoma; cervix; polymerase chain reaction;
D O I
10.1097/01.pgp.0000228141.01964.e7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In this paper, we report 2 new cases of villoglandular papillary adenocarcinoma (VGPA) of the cervix, a rare, well-differentiated form of cervical adenocarcinoma. Both patients were without medical complications or history of oral contraceptive use and were nonsmokers. Extended hysterectomy was performed in both cases. Morphological criteria for a correct pathological diagnosis were emphasized. Immunohistochemical analysis was performed to clarify the phenotype of the neoplasms. Moreover, for the first time, we probed to establish if VGPA could be correlated to human papilloma virus (HPV) and herpes virus (HSV) types I and 2, using polymerase chain reaction amplification of tumoral DNA. Both neoplasms showed positivity for B72.3, Ca-125, carcinoembryonic antigen, keratin 7, and p16(INK4a) protein. Vimentin, P53, estrogen, and progesterone receptors, instead, were negative. Molecular study by polymerase chain reaction amplification of tumor DNA revealed a strong positive signal for HPV-DNA and no signal for HSV-DNA. It is reasonable to conclude that our cases of VGPA, in accordance with other examples reported in literature, are due to HPV infection. Behavioral cofactors, such as HSV infection (types I and 2), oral contraceptive use and smoking, involved in the pathogenesis of other cervical malignancies, can be excluded for the present cases.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 30 条
[1]   Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray [J].
Alkushi, A ;
Irving, J ;
Hsu, F ;
Dupuis, B ;
Liu, CL ;
Rijn, M ;
Gilks, CB .
VIRCHOWS ARCHIV, 2003, 442 (03) :271-277
[2]   Villoglandular papillary adenocarcinoma of the cervix - Beware of a wolf in sheep's clothing [J].
Bouman, A ;
Oosterhuis, GJE ;
ten Cate, LN ;
van Doorn, GA .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 87 (02) :183-189
[3]   CERVICAL-CARCINOMA WITH GLANDULAR DIFFERENTIATION - HISTOLOGICAL-EVALUATION PREDICTS DISEASE RECURRENCE IN CLINICAL STAGE-I OR STAGE-II PATIENTS [J].
COSTA, MJ ;
MCILNAY, KR ;
TRELFORD, J .
HUMAN PATHOLOGY, 1995, 26 (08) :829-837
[4]   Villoglandular papillary adenocarcinoma of the uterine cervix in a pregnant woman: A case report and review of literature [J].
Dede, M ;
Deveci, G ;
Deveci, MS ;
Yenen, MC ;
Goktolga, U ;
Dilek, S ;
Gunhan, O .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 202 (04) :305-310
[5]  
DELVENNE P, 1994, MODERN PATHOL, V7, P113
[6]   A case of villoglandular papillary adenocarcinoma of the cervix with lymph node metastasis [J].
Garcea, A ;
Nunns, D ;
Ireland, D ;
Brown, L .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2003, 110 (06) :627-629
[7]   PCR AMPLIFICATION FROM PARAFFIN-EMBEDDED TISSUES - EFFECTS OF FIXATIVE AND FIXATION TIME [J].
GREER, CE ;
PETERSON, SL ;
KIVIAT, NB ;
MANOS, MM .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (02) :117-124
[8]   PAPILLARY VILLOGLANDULAR CARCINOMA OF THE CERVIX [J].
HOPSON, L ;
JONES, MA ;
BOYCE, CR ;
TARRAZA, HM .
GYNECOLOGIC ONCOLOGY, 1990, 39 (02) :221-224
[9]  
HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
[10]   WELL-DIFFERENTIATED VILLOGLANDULAR ADENOCARCINOMA OF THE UTERINE CERVIX - A CLINICOPATHOLOGICAL STUDY OF 24 CASES [J].
JONES, MW ;
SILVERBERG, SG ;
KURMAN, RJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1993, 12 (01) :1-7